![]() On returning to Canada in 1999, he became senior scientific advisor to the Public Health Agency of Canada, director general of the Centre for Infectious Disease Prevention and Control, and scientific director general of the National Microbiology Laboratory, where he remained for 13 years, leading the Canadian laboratory response to SARS and the H1N1 pandemic and overseeing the development of the successful VSV EBOV vaccine for Ebola viral hemorrhagic fever. His research described the heterosexual epidemiology of HIV, the increased risk of HIV infection in men associated with previous chancroid infection and of male circumcision in reducing such risk, and identified immunological and genetic features shared by a group of female sex workers who demonstrated immunity to HIV. While there, in 1982 he began studying AIDS transmission in 1982, and beginning in 1984 was part of a research collaboration in Nairobi between the University of Manitoba and the University of Nairobi studying sexually transmitted infections. In 1980, he went to Kenya in response to a request from the University of Nairobi for assistance in managing an outbreak of chancroid. He studied medicine at the University of Manitoba, where he specialized in infectious diseases. He was Distinguished Professor Emeritus of Medicine and Medical Microbiology at the University of Manitoba and Scientific Director General, National Microbiology Laboratory. ![]() He was "a recognized specialist in infectious diseases whose work influenced public health policy in Canada and abroad". Francis Allan Plummer OC OM FRSC (2 December 1952 – 4 February 2020) was a Canadian scientist, academic and HIV/ AIDS researcher. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |